- call +1-201-465-4211
- email sales@mrinsights.biz
The clinical trial imaging is majorly used to obtain human physiology or anatomy information’s which are undeniable as well as interpretable. The use of the imaging systems is mainly in the research and development, pharmaceutical and biotechnology sector, and medical sector. The systems help give accurate and effective information. The clinical trial images help evaluate the drug delivery mode, prevention, treatment, and identification of various medical conditions.
Scope of the Report:
The global Clinical Trial Imaging market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Clinical Trial Imaging.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Clinical Trial Imaging market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Clinical Trial Imaging market by product type and applications/end industries.
Market Segment by Companies, this report covers
Bioclinica
Parexel International Corporation
Icon
Biomedical Systems Corporation
Biotelemetry
Cardiovascular Imaging Technologies
Intrinsic Imaging
Ixico
Radiant Sage
Worldcare Clinical
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Computed Tomography
Magnetic Resonance Imaging
Ultrasound
X-Ray
Other Modalities
Market Segment by Applications, can be divided into
Pharmaceutical Companies
Biotechnology Companies
Medical Device Manufacturers
Research Institutes
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Clinical Trial Imaging Market Overview
1.1 Product Overview and Scope of Clinical Trial Imaging
1.2 Classification of Clinical Trial Imaging by Types
1.2.1 Global Clinical Trial Imaging Revenue Comparison by Types (2017-2023)
1.2.2 Global Clinical Trial Imaging Revenue Market Share by Types in 2017
1.2.3 Computed Tomography
1.2.4 Magnetic Resonance Imaging
1.2.5 Ultrasound
1.2.6 X-Ray
1.2.7 Other Modalities
1.3 Global Clinical Trial Imaging Market by Application
1.3.1 Global Clinical Trial Imaging Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Pharmaceutical Companies
1.3.3 Biotechnology Companies
1.3.4 Medical Device Manufacturers
1.3.5 Research Institutes
1.3.6 Others
1.4 Global Clinical Trial Imaging Market by Regions
1.4.1 Global Clinical Trial Imaging Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Clinical Trial Imaging Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Clinical Trial Imaging Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Clinical Trial Imaging Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Clinical Trial Imaging Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Clinical Trial Imaging Status and Prospect (2013-2023)
1.5 Global Market Size of Clinical Trial Imaging (2013-2023)
2 Manufacturers Profiles
2.1 Bioclinica
2.1.1 Business Overview
2.1.2 Clinical Trial Imaging Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bioclinica Clinical Trial Imaging Revenue, Gross Margin and Market Share (2016-2017)
2.2 Parexel International Corporation
2.2.1 Business Overview
2.2.2 Clinical Trial Imaging Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Parexel International Corporation Clinical Trial Imaging Revenue, Gross Margin and Market Share (2016-2017)
2.3 Icon
2.3.1 Business Overview
2.3.2 Clinical Trial Imaging Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Icon Clinical Trial Imaging Revenue, Gross Margin and Market Share (2016-2017)
2.4 Biomedical Systems Corporation
2.4.1 Business Overview
2.4.2 Clinical Trial Imaging Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Biomedical Systems Corporation Clinical Trial Imaging Revenue, Gross Margin and Market Share (2016-2017)
2.5 Biotelemetry
2.5.1 Business Overview
2.5.2 Clinical Trial Imaging Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Biotelemetry Clinical Trial Imaging Revenue, Gross Margin and Market Share (2016-2017)
2.6 Cardiovascular Imaging Technologies
2.6.1 Business Overview
2.6.2 Clinical Trial Imaging Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Cardiovascular Imaging Technologies Clinical Trial Imaging Revenue, Gross Margin and Market Share (2016-2017)
2.7 Intrinsic Imaging
2.7.1 Business Overview
2.7.2 Clinical Trial Imaging Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Intrinsic Imaging Clinical Trial Imaging Revenue, Gross Margin and Market Share (2016-2017)
2.8 Ixico
2.8.1 Business Overview
2.8.2 Clinical Trial Imaging Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Ixico Clinical Trial Imaging Revenue, Gross Margin and Market Share (2016-2017)
2.9 Radiant Sage
2.9.1 Business Overview
2.9.2 Clinical Trial Imaging Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Radiant Sage Clinical Trial Imaging Revenue, Gross Margin and Market Share (2016-2017)
2.10 Worldcare Clinical
2.10.1 Business Overview
2.10.2 Clinical Trial Imaging Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Worldcare Clinical Clinical Trial Imaging Revenue, Gross Margin and Market Share (2016-2017)
3 Global Clinical Trial Imaging Market Competition, by Players
3.1 Global Clinical Trial Imaging Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Clinical Trial Imaging Players Market Share
3.2.2 Top 10 Clinical Trial Imaging Players Market Share
3.3 Market Competition Trend
4 Global Clinical Trial Imaging Market Size by Regions
4.1 Global Clinical Trial Imaging Revenue and Market Share by Regions
4.2 North America Clinical Trial Imaging Revenue and Growth Rate (2013-2018)
4.3 Europe Clinical Trial Imaging Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Clinical Trial Imaging Revenue and Growth Rate (2013-2018)
4.5 South America Clinical Trial Imaging Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Clinical Trial Imaging Revenue and Growth Rate (2013-2018)
5 North America Clinical Trial Imaging Revenue by Countries
5.1 North America Clinical Trial Imaging Revenue by Countries (2013-2018)
5.2 USA Clinical Trial Imaging Revenue and Growth Rate (2013-2018)
5.3 Canada Clinical Trial Imaging Revenue and Growth Rate (2013-2018)
5.4 Mexico Clinical Trial Imaging Revenue and Growth Rate (2013-2018)
6 Europe Clinical Trial Imaging Revenue by Countries
6.1 Europe Clinical Trial Imaging Revenue by Countries (2013-2018)
6.2 Germany Clinical Trial Imaging Revenue and Growth Rate (2013-2018)
6.3 UK Clinical Trial Imaging Revenue and Growth Rate (2013-2018)
6.4 France Clinical Trial Imaging Revenue and Growth Rate (2013-2018)
6.5 Russia Clinical Trial Imaging Revenue and Growth Rate (2013-2018)
6.6 Italy Clinical Trial Imaging Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Clinical Trial Imaging Revenue by Countries
7.1 Asia-Pacific Clinical Trial Imaging Revenue by Countries (2013-2018)
7.2 China Clinical Trial Imaging Revenue and Growth Rate (2013-2018)
7.3 Japan Clinical Trial Imaging Revenue and Growth Rate (2013-2018)
7.4 Korea Clinical Trial Imaging Revenue and Growth Rate (2013-2018)
7.5 India Clinical Trial Imaging Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Clinical Trial Imaging Revenue and Growth Rate (2013-2018)
8 South America Clinical Trial Imaging Revenue by Countries
8.1 South America Clinical Trial Imaging Revenue by Countries (2013-2018)
8.2 Brazil Clinical Trial Imaging Revenue and Growth Rate (2013-2018)
8.3 Argentina Clinical Trial Imaging Revenue and Growth Rate (2013-2018)
8.4 Colombia Clinical Trial Imaging Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Clinical Trial Imaging by Countries
9.1 Middle East and Africa Clinical Trial Imaging Revenue by Countries (2013-2018)
9.2 Saudi Arabia Clinical Trial Imaging Revenue and Growth Rate (2013-2018)
9.3 UAE Clinical Trial Imaging Revenue and Growth Rate (2013-2018)
9.4 Egypt Clinical Trial Imaging Revenue and Growth Rate (2013-2018)
9.5 Nigeria Clinical Trial Imaging Revenue and Growth Rate (2013-2018)
9.6 South Africa Clinical Trial Imaging Revenue and Growth Rate (2013-2018)
10 Global Clinical Trial Imaging Market Segment by Type
10.1 Global Clinical Trial Imaging Revenue and Market Share by Type (2013-2018)
10.2 Global Clinical Trial Imaging Market Forecast by Type (2018-2023)
10.3 Computed Tomography Revenue Growth Rate (2013-2023)
10.4 Magnetic Resonance Imaging Revenue Growth Rate (2013-2023)
10.5 Ultrasound Revenue Growth Rate (2013-2023)
10.6 X-Ray Revenue Growth Rate (2013-2023)
10.7 Other Modalities Revenue Growth Rate (2013-2023)
11 Global Clinical Trial Imaging Market Segment by Application
11.1 Global Clinical Trial Imaging Revenue Market Share by Application (2013-2018)
11.2 Clinical Trial Imaging Market Forecast by Application (2018-2023)
11.3 Pharmaceutical Companies Revenue Growth (2013-2018)
11.4 Biotechnology Companies Revenue Growth (2013-2018)
11.5 Medical Device Manufacturers Revenue Growth (2013-2018)
11.6 Research Institutes Revenue Growth (2013-2018)
11.7 Others Revenue Growth (2013-2018)
12 Global Clinical Trial Imaging Market Size Forecast (2018-2023)
12.1 Global Clinical Trial Imaging Market Size Forecast (2018-2023)
12.2 Global Clinical Trial Imaging Market Forecast by Regions (2018-2023)
12.3 North America Clinical Trial Imaging Revenue Market Forecast (2018-2023)
12.4 Europe Clinical Trial Imaging Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Clinical Trial Imaging Revenue Market Forecast (2018-2023)
12.6 South America Clinical Trial Imaging Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Clinical Trial Imaging Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Clinical Trial Imaging Picture
Table Product Specifications of Clinical Trial Imaging
Table Global Clinical Trial Imaging and Revenue (Million USD) Market Split by P
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
